About
Sophie Blondel appears to be a France-based biotech entrepreneur and cell and gene therapy specialist associated with FoxBio. Public event and speaker pages identify her as Co-founder and CEO of FoxBio, a company described by HEC Paris as developing a new therapeutic paradigm for chronic inflammatory diseases. Separate hospitality and finance search hits likely refer to different individuals with the same name and are not merged here.
Areas of interest
biotechcell therapygene therapyadvanced therapeuticsdrug developmentchronic inflammatory diseaseshealthcare innovation